Recent Finacing
Recent Raise
Eloxx Pharmaceuticals is a biotech developing ELX-02, an aminoglycoside TRID restoring protein production from nonsense mutations; conducting Phase 1–2 trials in cystic fibrosis and cystinosis plus other genetic indications.
